Islamuddin Mohammad, Ali Abuzer, Khan Wajihul Hasan, Ali Amena, Hasan Syed Kazim, Abdullah Mohd, Kato Kentaro, Abdin Malik Zainul, Parveen Shama
Molecular Virology Laboratory, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India.
Laboratory of Sustainable Animal Environment, Graduate School of Agricultural Science, Tohoku University, Miyagi, Japan.
Infect Drug Resist. 2022 Jul 28;15:4065-4078. doi: 10.2147/IDR.S347545. eCollection 2022.
Chikungunya is caused by an alpha virus transmitted to humans by an infected mosquito. Infection is generally considered to be self-limiting and non-critical. Chikungunya infection may be diagnosed by severe joint pain with fever, but it is difficult to diagnose because the symptoms of chikungunya are common to many pathogens, including dengue fever. Diagnosis mainly depends on viral culture, reverse transcriptase polymerase chain reaction (RT-PCR), and IgM ELISA. Early and accurate diagnosis of the virus can be achieved by the application of PCR methods, but the high cost and the need for a thermal cycler restrict the use of such methods. On the other hand, antibody-based IgM ELISA is considered to be inexpensive, but antibodies against chikungunya virus (CHIKV) only develop after 4 days of infection, so it has limited application in the earlier diagnosis of viral infection and the management of patients. Because of these challenges, a simple antigen-based sensitive, specific, and rapid detection method is required for the early and accurate clinical diagnosis of chikungunya.
The amino acid sequence of CHIKV ectodomain E1 and E2 proteins was analyzed using bioinformatics tools to determine the antigenic residues, particularly the B-cell epitopes and their characteristics. Recombinant E2-E1 CHIKV antigen was used for the development of polyclonal antibodies in hamsters and IgG was purified. Serological tests of 96 CHIKV patients were conducted by antigen-capture ELISA using primary antibodies raised against rCHIKV E2-E1 in hamsters and human anti-CHIKV antibodies.
We observed high specificity and sensitivity, of 100% and 95.8%, respectively, and these values demonstrate the efficiency of the test as a clinical diagnostic tool. There was no cross-reactivity with samples taken from dengue patients.
Our simple and sensitive sandwich ELISA for the early-phase detection of CHIKV infection may be used to improve the diagnosis of chikungunya.
基孔肯雅热由一种α病毒引起,该病毒通过受感染的蚊子传播给人类。一般认为感染是自限性的且不严重。基孔肯雅热感染可通过伴有发热的严重关节疼痛来诊断,但由于基孔肯雅热的症状与包括登革热在内的许多病原体的症状相似,因此难以诊断。诊断主要依靠病毒培养、逆转录聚合酶链反应(RT-PCR)和IgM酶联免疫吸附测定(ELISA)。应用PCR方法可实现病毒的早期准确诊断,但成本高且需要热循环仪限制了此类方法的使用。另一方面,基于抗体的IgM ELISA被认为成本低廉,但针对基孔肯雅病毒(CHIKV)的抗体在感染4天后才会产生,因此其在病毒感染的早期诊断和患者管理中的应用有限。由于这些挑战,需要一种基于抗原的简单、灵敏、特异且快速的检测方法,用于基孔肯雅热的早期准确临床诊断。
使用生物信息学工具分析CHIKV外膜蛋白E1和E2的氨基酸序列,以确定抗原残基,特别是B细胞表位及其特征。重组E2-E1 CHIKV抗原用于在仓鼠中制备多克隆抗体并纯化IgG。使用针对仓鼠中rCHIKV E2-E1产生的一抗和人抗CHIKV抗体,通过抗原捕获ELISA对96例CHIKV患者进行血清学检测。
我们观察到特异性和灵敏度分别高达100%和95.8%,这些数值证明了该检测作为临床诊断工具的有效性。与登革热患者的样本无交叉反应。
我们用于早期检测CHIKV感染的简单灵敏夹心ELISA可用于改善基孔肯雅热的诊断。